Name: CTTH Income Statement - Ctt Pharmaceutical Holdings. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CTTH - Ctt Pharmaceutical Holdings. Inc.

USD | OTC Markets | Healthcare

CTTH Income Statement - Ctt Pharmaceutical Holdings. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q3 FY 15	Q2 FY 15	Q1 FY 15	Q4 FY 14	Q3 FY 14	Q2 FY 14	Q1 FY 14	Q4 FY 13	Q3 FY 13	Q2 FY 13	Q1 FY 13	Q4 FY 12	Q3 FY 12	Q2 FY 12	Q1 FY 12	Q4 FY 11	Q3 FY 11	Q2 FY 11	Q1 FY 11	Q3 FY 10	Q2 FY 10
Revenues
Revenues	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2014	FY2013	FY2012	FY2011	FY2010
Revenues
Revenues	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-	-
Operating Income
Operating Income	-	(0.7)	(0.0)	(1.2)	(0.8)	(2.1)
Non-Operating
Interest Income	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Income From Equity Investments
Tax & Net
Income Tax Expense	-	-	-	-	-	-
Net Income From Continuing Ops	(1.7)	(0.7)	(0.0)	(1.0)	3.7	(1.1)
Net Income From Discontinued Ops
Per Share
EPS Basic	-	-	0.01	(0.11)	0.42	(0.13)
EPS Diluted	-	-	0.01	(0.11)	0.40	(0.13)
Shares Basic
Supplementary Data
EBITDA	-	-	-	-	(0.8)	(2.0)
EBIT	-	(0.7)	(0.0)	(1.2)	(0.8)	(2.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	-	-	(0.3)	-	-	(0.0)	(0.0)	0.1	(0.0)	(0.1)	(0.1)	(0.3)	(0.1)	(0.2)	(0.6)	(0.2)	(0.1)	(0.4)	(0.0)	(1.0)	(0.4)

Tax & Net
Income Tax Expense	-	-	-	-	-	-	-	-	0.0	-	-	-	0.0	-	-	-	0.0	-	-	-	-
Net Income From Continuing Ops	(0.3)	(0.4)	(0.3)	(0.6)	(0.0)	(0.0)	(0.0)	0.1	(0.0)	(0.1)	(0.0)	(0.3)	(0.1)	(0.0)	(0.6)	(1.4)	(0.1)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(0.3)	(0.4)	(0.3)	(0.6)	(0.0)	(0.0)	(0.0)	0.1	(0.0)	(0.1)	(0.0)	(0.3)	(0.1)	(0.0)	(0.6)	(1.4)	(0.1)
Net Income Attributable To Parent	(0.3)	(0.4)	(0.3)	(0.6)	(0.0)	(0.0)	(0.0)	0.1	(0.0)	(0.1)	(0.0)	(0.3)	(0.1)	(0.0)	(0.6)	(0.4)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(0.3)	(0.4)	(0.3)	(0.6)	(0.0)	(0.0)	(0.0)	0.1	(0.0)	(0.1)	(0.0)	(0.3)	(0.1)	(0.0)	(0.6)

Per Share
EPS Basic	-	-	-	-	0.01	0.00	0.00	-	(0.01)	(0.01)	(0.01)	-	(0.01)	0.00	(0.06)	-	(0.05)	(0.12)	0.64	(0.05)	0.00
EPS Diluted	-	-	-	-	-	0.00	0.00	-	0.00	(0.01)	(0.01)	-	(0.01)	0.00	(0.06)	-	(0.05)	(0.12)
Shares Basic	-	-	-	-	-	22.3	9.4	-	9.4	9.4	9.4	-	9.3	9.3	9.4	-	8.9	8.9
Shares Diluted	-	-	-	-	-	22.3	9.4	-	9.4	9.4	9.4	-	9.3	9.3	9.5	-	8.9	8.9

Supplementary Data
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	(0.1)	-	-	(1.0)	(0.4)
EBIT	-	-	(0.3)	-	-	(0.0)	(0.0)	0.1	(0.0)	(0.1)	(0.1)	(0.3)	(0.1)	(0.2)	(0.6)	(0.2)	(0.1)	(0.4)	(0.0)